Lineage Cell Therapeutics Inc (LCTX) — Net Asset Quality Index

Latest as of September 2025: 23.2%

Lineage Cell Therapeutics Inc (LCTX) has a Net Asset Quality Index of 23.2% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $89.64 Million minus total liabilities of $68.84 Million yields net assets of $20.80 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check LCTX financial resilience to evaluate the company's liquid asset resilience ratio.

Quality Index

23.2%
Equity / Total Assets

Net Assets

$20.80 Million
USD

Total Assets

$89.64 Million
USD

Total Liabilities

$68.84 Million
USD

Lineage Cell Therapeutics Inc Net Asset Quality Index Over Time (1991–2024)

This chart shows how Lineage Cell Therapeutics Inc's Net Asset Quality Index has evolved across 34 annual periods from 1991 to 2024. As of September 2025, the index stands at 23.2%, representing net assets of $20.80 Million against total assets of $89.64 Million USD. See LCTX current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Annual Net Asset Quality Index for Lineage Cell Therapeutics Inc (1991–2024)

The table below presents the year-by-year Net Asset Quality Index for Lineage Cell Therapeutics Inc from 1991 to 2024, covering 34 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Lineage Cell Therapeutics Inc market capitalisation.

Year Quality Index Net Assets (USD) Total Assets Total Liabilities Change (pp)
2024 68.0% $77.01 Million $113.22 Million $36.21 Million ▲ +6.6 pp
2023 61.4% $62.02 Million $101.02 Million $39.00 Million ▲ +3.2 pp
2022 58.2% $71.94 Million $123.66 Million $51.73 Million ▲ +6.1 pp
2021 52.1% $90.90 Million $174.54 Million $83.65 Million ▼ -36.0 pp
2020 88.1% $95.13 Million $107.95 Million $12.82 Million ▼ -0.5 pp
2019 88.7% $111.25 Million $125.48 Million $14.23 Million ▼ -2.1 pp
2018 90.7% $92.25 Million $101.66 Million $9.41 Million ▼ -4.1 pp
2017 94.8% $164.26 Million $173.24 Million $8.98 Million ▲ +3.3 pp
2016 91.5% $130.51 Million $142.57 Million $12.06 Million ▲ +10.8 pp
2015 80.8% $76.45 Million $94.66 Million $18.21 Million ▼ -3.0 pp
2014 83.7% $62.72 Million $74.90 Million $12.18 Million ▲ +10.5 pp
2013 73.2% $42.26 Million $57.73 Million $15.47 Million ▼ -8.5 pp
2012 81.7% $24.29 Million $29.75 Million $5.45 Million ▼ -8.8 pp
2011 90.5% $41.46 Million $45.83 Million $4.37 Million ▼ -2.3 pp
2010 92.8% $49.43 Million $53.27 Million $3.85 Million ▲ +10.5 pp
2009 82.2% $11.05 Million $13.43 Million $2.39 Million ▲ +502.0 pp
2008 -419.8% $-4.35 Million $1.04 Million $5.38 Million ▲ +1320.0 pp
2007 -1739.8% $-3.05 Million $175.10K $3.22 Million ▼ -1453.0 pp
2006 -286.7% $-1.87 Million $650.51K $2.52 Million ▼ -276.7 pp
2005 -10.0% $-196.58K $1.96 Million $2.16 Million ▼ -32.7 pp
2004 22.7% $344.77K $1.52 Million $1.18 Million ▲ +249.5 pp
2003 -226.8% $-2.43 Million $1.07 Million $3.50 Million ▼ -148.5 pp
2002 -78.3% $-1.17 Million $1.50 Million $2.67 Million ▼ -73.2 pp
2001 -5.1% $-99.09K $1.94 Million $2.04 Million ▼ -83.7 pp
2000 78.6% $1.32 Million $1.68 Million $359.75K ▼ -11.0 pp
1999 89.5% $5.08 Million $5.68 Million $595.51K ▲ +3.8 pp
1998 85.7% $2.40 Million $2.80 Million $400.00K ▲ +7.4 pp
1997 78.3% $6.50 Million $8.30 Million $1.80 Million ▼ -15.0 pp
1996 93.3% $2.80 Million $3.00 Million $200.00K ▲ +0.0 pp
1995 93.3% $2.80 Million $3.00 Million $200.00K ▲ +4.4 pp
1994 88.9% $3.20 Million $3.60 Million $400.00K ▼ -9.4 pp
1993 98.3% $5.80 Million $5.90 Million $100.00K ▲ +1.2 pp
1992 97.1% $3.40 Million $3.50 Million $100.00K ▲ +1.3 pp
1991 95.8% $4.60 Million $4.80 Million $200.00K
pp = percentage points